SOLVING UNKNOWN PRIMARY CANCER (SUPER PLUS): INTEGRATING MOLECULAR TESTS TO DEFINE SITE OF ORIGIN AND THERAPEUTICALLY ACTIONABLE MUTATIONS TO IMPROVE THE MANAGEMENT OF CANCINOMA OF UNKNOWN PRIMARY

| Funding period: 2014 - 2019

Completed